Showing 11 - 12 of 12
Based on this review there is a dearth of up-to-date, robust evidence on the cost effectiveness of radiotherapy in cancer suitable to support decision making in the UK. Studies selected did not fully satisfy essential method standards currently recommended by NICE. </AbstractSection> Copyright The Author(s) 2014
Persistent link: https://www.econbiz.de/10011000821
Persistent link: https://www.econbiz.de/10005756084